Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments

Area of Science:

• Biomedical Engineering
• Cancer Biology
• Microfluidics

Background:

• The tumor microenvironment significantly impacts cancer progression and treatment response.
• Understanding 3D microenvironmental cues is crucial for developing effective cancer therapies.
• Existing tools lack the capability to systematically probe these cues in a 3D context.

Purpose of the Study:

• To develop a high-throughput microfluidic platform for creating tunable cellular microniches (microtissues).
• To investigate tumor cell responses to various microenvironmental factors within a 3D context.
• To enable rapid, population-level analysis and sorting of microtissues for drug screening and basic research.

Main Methods:

• Fabrication of tunable cellular microniches using microfluidic technology.
• High-throughput, flow-based population analysis of microtissues (n > 500).
• Assessment of tumor cell proliferation and density in response to extracellular matrix (ECM) components and soluble factors.

Main Results:

• Lung adenocarcinoma cells showed differential proliferation based on ECM composition (fibronectin vs. collagen-1).
• Transforming growth factor-beta (TGF-β) reduced proliferation in 3D microtissues, an effect not seen in 2D monolayer cultures.
• Tumor cells exhibited specific sensitivity to TGF-β receptor 2 (TGFβR2) inhibitors in 3D, indicating TGF-β's anti-proliferative role is context-dependent.

Conclusions:

• The 3D cancer microenvironment critically influences tumor cell behavior and drug response.
• The developed microfluidic platform facilitates high-throughput studies of tumor biology and drug efficacy in defined 3D niches.
• Targeting pathways like TGF-β may offer unique therapeutic opportunities when considering the 3D tumor context.